BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

FDA Clearance for Lexington International, LLC's HairMax LaserComb Fills Unmet Need of Providing an Effective, Non-drug Home-use Device for Treating Hair Loss


10/21/2011 9:14:23 AM

Boca Raton, FL (PRWEB) October 21, 2011 -- Lexington International, LLC, is pleased to announce that the company has received Class II FDA 510(k) #K112524 Marketing Clearance for two new models of the HairMax LaserComb®, laser phototherapy medical device for the treatment of hereditary hair loss in women.

FDA Clearance Letter Link:

http://hairmax.com/mediakit/docs/FDA_Clearance_adv7_pro12.pdf

Hereditary hair loss is a devastating condition affecting over 30 million women in the United States. Until recently, when the HairMax Lux 9 was initially FDA Cleared for marketing for treatment of females, there had been only one FDA approved drug for treating this condition in women. This latest FDA Clearance now expands the HairMax treatment options for the HairMax LaserComb models, as an effective first-line treatment of hereditary hair loss in both men and women. This is the fourth FDA 510(k) Clearance for marketing granted to Lexington Int’l this year.

The HairMax LaserComb cordless models that are now available are the HairMax Advanced 7, the HairMax Lux 9, and the HairMax Professional 12. These devices are offered at varying price points which fit the needs of all people wishing to treat their hair loss condition. The HairMax is easy and convenient to use with treatments at home of just 9-15 minutes per day, three times per week to achieve results, which can be seen in as little as 12 weeks. Also, the HairMax is safe to use, as no serious side effects have ever been reported from use of the HairMax.

This FDA marketing Clearance for females combined with prior FDA marketing Clearance for males, provides the following official indication for the HairMax LaserComb.

The HairMax Advanced 7, Lux9, and the Professional 12 models are indicated to treat Androgenetic Alopecia, and promote hair growth in males who have Norwood Hamilton Classifications of IIa to V and in females who have Ludwig (Savin) I-4, II-1, II-2, or frontal patterns of hair loss and who both have Fitzpatrick Skin Types I to IV.

This latest milestone is the culmination of Lexington’s goal to offer a complete line of innovative, cutting edge, phototherapy devices for treating hereditary hair loss in men and women around the world. These testimonials from satisfied users of the HairMax are typical of the numerous comments we have received: “It got to the point that I wasn’t going out much anymore. I noticed that when I spoke to my relatives and friends they weren’t looking directly at me – they were looking at my hairline and that made me feel even more self-conscious about my hair loss.” And, “HairMax has rejuvenated my hair growth, my self-esteem and my confidence.”

Link to other testimonials:

http://hairmax.com/share-your-lasercomb-review and http://www.hairmax.com/lasercomb-reviews-testimonials

In four double-blind clinical studies on the treatment of androgenetic alopecia (hereditary hair loss) in both men and women over 93% of subjects in the HairMax LaserComb groups experienced hair growth at 6 months. These results were consistent in all studies showing that the results with the HairMax are reproducible and predictable. Since 2001, Lexington has completed a total of seven clinical studies with 460 subjects. All of the studies (including these four), have conclusively proven that the HairMax LaserComb family of products are efficacious and safe as first line therapy for appropriate classes of hereditary hair loss.

Mr. David Michaels, Managing Director of Lexington said, “We have spent 11 years of R & D, innovation, and the completion of seven clinical studies to bring these innovative products to market. This recent FDA marketing Clearance brings to fruition our goal of offering a complete line of laser phototherapy products for people who are suffering from hereditary hair loss. Our challenge now is not how to get there, but how to assure that we get this information about the HairMax out to the millions of people suffering from this devastating condition.”

Randy Veliky, Lexington COO said: “This recent FDA Clearance means that the HairMax LaserComb with its patented technology and state of the art design, now solidifies the position of Lexington as the world-wide leader in the treatment of hair loss. No other company marketing a device of its kind for hair loss matches the breadth, scope, and depth of our product line.”

About Lexington International, LLC

Based in Boca Raton, Lexington International is a manufacturer and developer of advanced medical laser devices to treat hair loss and scalp disorders. Lexington Int’l markets the only laser phototherapy device which has published results of clinical trial proving efficacy and safety in a peer review journal. The company, was one of just 14 leading manufacturing exporting companies nationwide to receive the 2009 U.S. President’s “E” Award, which recognizes successes in world markets and subsequent contributions to the U.S. economy. Over the past 10 years and in over 155 countries worldwide, Lexington has helped hundreds of thousands of individuals to treat their hair condition and enrich their lives.

(http://www.hairmax.com)



Read at BioSpace.com
Read at News Release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES